Panacea Life Sciences Holdings Inc (PLSH): CASE NUMBER: 50-2016-CA-013451-XXXX-MB...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Panacea Life Sciences Holdings Inc (PLSH)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

DrKrassenDimitrov

Send PM Follow Ignore

Followers	1
Posts	70
Boards Moderated	0
Alias Born	02/27/2019

DrKrassenDimitrov

Re: tigerpac post# 789

Wednesday, 03/11/2020 2:49:37 PM

Wednesday, March 11, 2020 2:49:37 PM

CASE NUMBER: 50-2016-CA-013451-XXXX-MB
CASE STYLE: HUGHES, THOMAS P V LUKENS GROUP, LLC

Puzder was CFO and/or President of Lukens and is named as defendant in the amended complaints.

Allegation is Lukens/Puzder allegedly solicited loans from employees and others, without disclosure of the actual state of the company. Lukens Group is now in bankruptcy and the case is stayed, pending the bankruptcy outcome...

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent PLSH News

Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 04:21:21 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:28:18 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 03:19:11 PM
Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast • InvestorsHub NewsWire • 07/18/2023 04:41:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 01:00:13 PM

More PLSH News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow